Xcovery
Manufacturing · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11780 Us Hwy 1 Ste 202, North Palm Beach...Phone Number
(561) 835-9356Website
www.xcovery.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Xcovery
At Xcovery, the company's mission is simple: to employ advanced science to create leading-edge oncology therapies that are not only more effective than current options but are also less toxic and more tolerable for those who need them. By combining the company's passion for science with compassion for humanity, the company works to ensure that life-changing agents move from research to real life as quickly as possibleso people courageously living with cancer can go on living with greater grace and dignity, and the oncology community can more effectively help patients live longer, happier, healthier lives.Explore more
Xcovery Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xcovery your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Xcovery is spiking on competitors!
Check if Xcovery has recently received funding, and reach out quickly before it becomes old news!
Xcovery, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Xcovery recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Xcovery has new funding data
Product Launch: Get notified when Xcovery launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Xcovery
Click to see if Xcovery had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Xcovery
Compare insights from companies similar to Xcovery, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Xcovery is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xcovery is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xcovery.
Xcovery financials insights
Gather financial insights about Xcovery, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$2.4M
2012
Series B
$6M
2013
Debt
$2.1M
2014
Multiple Rounds
$38.1M
2020
Debt
$350K
Xcovery Tech Stack
A closer look at the technologies used by Xcovery
See more technologies
Most Recent Scoops
Promotion
Executive Move
Promotion
Left Company
Executive Move
Left Company
Funding
Xcovery has received an SBA PPP loan for $350,000-1 million from JPMorgan Chase Bank, supporting the retention of 10 jobs.
New Hire
Executive Move
Giovanni Selvaggi has been named Chief Medical Officer. In this role, Selvaggi is responsible for the management of the medical operations of the company. Previously, Selvaggi served as Program Lead at Bristol-Myers Squibb.
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Xcovery News & Media
FDA Approval of Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
MIAMI--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). This approval marks an important advancement in providing a new first line option for patients with ALK-positive NSCLC. Ensartinib is an ALU.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinib
MIAMI--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ensartinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor for the treatment of adult patients with metastatic ALK-positive non-small cell lung cancer (NSCLC). The filing is based on the results of the eXalt3, a randomized global phase III study designed to evaluate the efficacy and safety of eXcovery SHP2 Inhibitor IND Approved by US FDA
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational New Drug application (IND) of BPI-442096 , a small molecule Src homology region 2 domain-containing phosphatase 2 (SHP2) inhibitor, in solid tumors. Xcovery will initiate a phase I clinical trial in the United States to assess the tolerability, safety, and efficacy of BPI-442096 . BPI-Ensartinib Secured Its First Approval for 1st Line Treatment in ALK+ NSCLC
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology focused bio-pharmaceutical company, today announced that Xcovery’s affiliate Betta Pharmaceuticals has received the National Medical Products Administration (NMPA)’s approval of ensartinib in China for the first-line treatment of ALK-positive non-small cell lung cancer (NSCLC). Ensartinib has been previously approved for the second-line treatment of ALK-positive NSCLC in China in 2020. Ensartinib is a next generation
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xcovery
Sign Up For FreeTo access detailed company insights
At Xcovery, the company's mission is simple: to employ advanced science to create leading-edge oncology therapies that are not only more effective than current options but are also less toxic and more tolerable for those who need them. By combining the company's passion for science with compassion for humanity, the company works to ensure that life... Read More
